BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
106.33
-0.24 (-0.23%)
At close: Jun 16, 2025, 4:00 PM
106.13
-0.20 (-0.19%)
Pre-market: Jun 17, 2025, 4:00 AM EDT

BioNTech SE Statistics

Total Valuation

BioNTech SE has a market cap or net worth of $25.56 billion. The enterprise value is $10.63 billion.

Market Cap 25.56B
Enterprise Value 10.63B

Important Dates

The next estimated earnings date is Monday, August 4, 2025, before market open.

Earnings Date Aug 4, 2025
Ex-Dividend Date n/a

Share Statistics

BioNTech SE has 240.39 million shares outstanding. The number of shares has decreased by -0.51% in one year.

Current Share Class n/a
Shares Outstanding 240.39M
Shares Change (YoY) -0.51%
Shares Change (QoQ) +0.03%
Owned by Insiders (%) 18.34%
Owned by Institutions (%) 22.94%
Float 93.81M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 8.61
Forward PS 12.93
PB Ratio 1.25
P/TBV Ratio 1.39
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 3.58
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 10.18, with a Debt / Equity ratio of 0.02.

Current Ratio 10.18
Quick Ratio 9.86
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -80.81

Financial Efficiency

Return on equity (ROE) is -3.94% and return on invested capital (ROIC) is -4.05%.

Return on Equity (ROE) -3.94%
Return on Assets (ROA) -3.67%
Return on Invested Capital (ROIC) -4.05%
Return on Capital Employed (ROCE) -6.50%
Revenue Per Employee $438,324
Profits Per Employee -$122,258
Employee Count 6,772
Asset Turnover 0.13
Inventory Turnover 1.89

Taxes

Income Tax -27.35M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +15.48% in the last 52 weeks. The beta is 1.29, so BioNTech SE's price volatility has been higher than the market average.

Beta (5Y) 1.29
52-Week Price Change +15.48%
50-Day Moving Average 100.77
200-Day Moving Average 108.88
Relative Strength Index (RSI) 53.88
Average Volume (20 Days) 1,288,689

Short Selling Information

Short Interest 5.20M
Short Previous Month 5.38M
Short % of Shares Out 5.63%
Short % of Float n/a
Short Ratio (days to cover) 5.78

Income Statement

In the last 12 months, BioNTech SE had revenue of $2.97 billion and -$827.93 million in losses. Loss per share was -$3.45.

Revenue 2.97B
Gross Profit 2.36B
Operating Income -1.38B
Pretax Income -269.98M
Net Income -827.93M
EBITDA -1.10B
EBIT -1.38B
Loss Per Share -$3.45
Full Income Statement

Balance Sheet

The company has $15.25 billion in cash and $316.69 million in debt, giving a net cash position of $14.93 billion or $62.12 per share.

Cash & Cash Equivalents 15.25B
Total Debt 316.69M
Net Cash 14.93B
Net Cash Per Share $62.12
Equity (Book Value) 20.46B
Book Value Per Share 85.10
Working Capital 15.23B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$276.37 million and capital expenditures -$299.29 million, giving a free cash flow of -$615.37 million.

Operating Cash Flow -276.37M
Capital Expenditures -299.29M
Free Cash Flow -615.37M
FCF Per Share -$2.56
Full Cash Flow Statement

Margins

Gross margin is 79.39%, with operating and profit margins of -46.49% and -27.89%.

Gross Margin 79.39%
Operating Margin -46.49%
Pretax Margin -28.81%
Profit Margin -27.89%
EBITDA Margin -37.14%
EBIT Margin -46.49%
FCF Margin n/a

Dividends & Yields

BioNTech SE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 0.51%
Shareholder Yield 0.51%
Earnings Yield -3.24%
FCF Yield -2.41%
Dividend Details

Analyst Forecast

The average price target for BioNTech SE is $141.55, which is 33.12% higher than the current price. The consensus rating is "Strong Buy".

Price Target $141.55
Price Target Difference 33.12%
Analyst Consensus Strong Buy
Analyst Count 18
Revenue Growth Forecast (5Y) 3.84%
EPS Growth Forecast (5Y) -14.76%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

BioNTech SE has an Altman Z-Score of 8.04 and a Piotroski F-Score of 3.

Altman Z-Score 8.04
Piotroski F-Score 3